These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 16599291)

  • 21. Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease.
    Poirier J
    Mol Diagn; 1999 Dec; 4(4):335-41. PubMed ID: 10671644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is apolipoprotein E4 an important risk factor for vascular dementia?
    Rohn TT
    Int J Clin Exp Pathol; 2014; 7(7):3504-11. PubMed ID: 25120729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions.
    Plassman BL; Breitner JC
    J Am Geriatr Soc; 1996 Oct; 44(10):1242-50. PubMed ID: 8856006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.
    Cacabelos R; Fernández-Novoa L; Corzo L; Amado L; Pichel V; Lombardi V; Kubota Y
    Neurol Res; 2004 Jul; 26(5):459-80. PubMed ID: 15265264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of subcortical vascular dementia.
    Schmidt H; Freudenberger P; Seiler S; Schmidt R
    Exp Gerontol; 2012 Nov; 47(11):873-7. PubMed ID: 22735669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-onset Alzheimer's disease in Scotland: environmental and familial factors.
    Whalley LJ
    Br J Psychiatry Suppl; 2001 Apr; 40():s53-9. PubMed ID: 11315226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of vascular dementia - review from the ICVD working group.
    Ikram MA; Bersano A; Manso-Calderón R; Jia JP; Schmidt H; Middleton L; Nacmias B; Siddiqi S; Adams HH
    BMC Med; 2017 Mar; 15(1):48. PubMed ID: 28260527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.
    Cardona-Gómez GP; Lopera F
    Front Aging Neurosci; 2016; 8():304. PubMed ID: 28066230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic studies of dementias in Taiwan.
    Chen HH; Hu CJ
    Acta Neurol Taiwan; 2006 Mar; 15(1):60-3. PubMed ID: 16599291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic characteristics of dementia in Taiwan.
    Chen HH; Hu CJ
    Acta Neurol Taiwan; 2006 Sep; 15(3):161-9. PubMed ID: 16995595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOE ε4: the most prevalent yet understudied risk factor for Alzheimer's disease.
    Michaelson DM
    Alzheimers Dement; 2014 Nov; 10(6):861-8. PubMed ID: 25217293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of APOE in dementia: A critical reappraisal.
    de Knijff P; van Duijn CM
    Haemostasis; 1998; 28(3-4):195-201. PubMed ID: 10420066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.
    Bullido MJ; Valdivieso F
    Microsc Res Tech; 2000 Aug; 50(4):261-7. PubMed ID: 10936877
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.